[1]许中兴 董翔宇 王霆 刘永 周立英 王冬 冯艳 王凤霞.冠状动脉慢性完全闭塞合并左室射血分数轻度降低的心力衰竭患者介入术后短期不良心血管事件的预测模型建立[J].心血管病学进展,2024,(11):1033.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.016]
　XU Zhongxing,DONG Xiangyu,WANG Ting,et al.Predictive Modeling of Short-Term Adverse Cardiovascular Events After Intervention in Patients with Coronary A rtery C hronic Total Occlusion Combined with Heart Failure with Mildly Reduced Left Ventricular Ejection Fraction[J].Advances in Cardiovascular Diseases,2024,(11):1033.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.016]
点击复制

冠状动脉慢性完全闭塞合并左室射血分数轻度降低的心力衰竭患者介入术后短期不良心血管事件的预测模型建立()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年11期
页码:
1033
栏目:
论著
出版日期:
2024-11-25

文章信息/Info

Title:
Predictive Modeling of Short-Term Adverse Cardiovascular Events After Intervention in Patients with Coronary A rtery C hronic Total Occlusion Combined with Heart Failure with Mildly Reduced Left Ventricular Ejection Fraction
作者:
许中兴1 董翔宇1 王霆1 刘永1 周立英1 王冬2 冯艳2 王凤霞1
(1.新疆维吾尔自治区人民医院心脏及泛血管医学诊疗中心心血管内科,新疆 乌鲁木齐 830001;2.新疆维吾尔自治区人民医院心脏及泛血管医学诊疗中心心电学科,新疆 乌鲁木齐 830001)
Author(s):
XU Zhongxing 1; DONG Xiangyu 1; WANG Ting 1; LIU Yong 1; ZHOU Liying 1; WANG Dong 2; FENG Yan 2; WANG Fengxia 1?/html>
(1.Cardiovascular Medicine Department,Heart and Panvascular Medicine Diagnosis and Treatment Center,People’s Hospital of Xinjiang Uygur Autonomous Region,Urumqi 830001, Xinjiang,China; 2.Department of Electrocardiology,Heart and Panvascular Medicine Diagnosis and Treatment Center,People’s Hospital of Xinjiang Uygur Autonomous Region,Urumqi 830001,Xinjiang,China)
关键词:
冠状动脉慢性完全闭塞; 左室射血分数轻度降低; 经皮冠状动脉介入治疗; 不良心血管事件; 列线图预测模型
Keywords:
Coronary artery chronic total occlusion; Mildly reduc ed left ventricular ejection fraction; Percutaneous coronary i ntervention; Adverse cardiovascular events; Nomogram prediction model
DOI:
10.16806/j.cnki.issn.1004-3934.2024.11.016
摘要:
目的 预测冠 状动脉慢性完全闭塞（CTO）合并左室射血分数轻度降低的心力衰竭（HFmrEF）患者行经皮冠状动脉介入治疗（PCI）后短期主要不良心血管事件（MACE）风险的发生，构建列线图预测模型并评价其性能。方法 回顾性选取2020年9月1日 —2023年3月1日就诊于新疆维吾尔自治区人民医院的CTO合并HFmrEF并行PCI患者共364例作为研究对象，术后随访1年，采用logistic回归分析预测PCI后发生MACE的独立危险因素，采用多因素分析构建列线图预测模型并采用Bootstrap法对模型进行内部验证；采用ROC曲线、曲线下面积（AUC）、校准曲线和决策曲线评估模型的准确度、预测效能和临床净获益。结果 多元logistic分析显示，心律失常病史、病变开通、血红蛋白、N末端脑钠肽前体和中性粒细胞/淋巴细胞比值为预测PCI后MACE发生的独立危险因素，以此构建的列线图经内部验证，AUC为0.919（95％ CI 0.890～0.947），具有较好的一致性。决策曲线显示此预测模型可提供额外的 临床净获益。结论 本研究构建的预测CTO合并HFmrEF患者PCI后发生短期MACE的列线图模型具有较好的预测效能，有助于医护人员尽早制定对策，降低MACE的发生风险，提高患者生存 概率。
Abstract:
Objective To predict the occurrence of short-term risk of major adverse cardiovascular event(MACE) after percutaneous coronary intervention(PCI) in patients with coronary artery chronic total occlusion(CTO) combined with heart failure with mildly reduced left ventricular ejection fraction(HFmrEF), to construct a nomogram prediction model and to evaluate its performance. Methods A total of 364 patients with CTO combined with HFmrEF who underwent PCI in People’s Hospital of Xinjiang Uygur Autonomous Region from September 1,2020 to March 1,202 3 were retrospectively selected as the study subjects,and were followed up for 1 year after the procedure. Logistic regression analysis was used to predict the independent risk factors for the occurrence of MACE after PCI, multifactorial analysis was used to construct a nomogram prediction model and the model was internally validated using the Bootstrap method;the accuracy,predictive efficacy and net clinical benefit of the model were assessed using the ROC curve ,area under the curve(AUC),calibration curve and decision curve. Results Multivariate logistic analysis showed that arrhythmia history,lesion opening,hemoglobin,N-terminal pro-brain natriuretic peptide and neutrophil to lymphocyte ratio were independent risk factors for predicting the occurrence of MACE after PCI,and the nomograms constructed in this way was internally validated with an AUC of 0.919(95% CI 0.890 ～0.947),which was in good agreement. The decision curve showed that this predictive model could provide additional net clinical benefit. Conclusion The nomogram prediction model constructed in this study to predict the occurrence of short-term MACE after PCI in patients with CTO combined with HFmrEF has good predictive efficacy,which can help healthcare professionals to formulate countermeasures as early as possible to reduce the risk of MACE and improve the chances of patient survival

参考文献/References:

[1] Ikoma T,Obokata M,Okada K,et al. Impact of right atrial remodeling in heart failure with preserved ejection fraction[J]. J Card Fail,2021,27(5):577-584.

[2] Writing committee of the report on cardiovascular health and diseases in China.Report on cardiovascular health and diseases in China 2021:an updated summary[J]. Biomed Environ Sci,2022,35(7):573-603.

[3] Bozkurt B,Coats AJS,Tsutsui H,et al. Universal definition and classification of heart failure:a report of the Heart Failure Society of America,Heart Failure Association of the European Society of Cardiology,Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure:Endorsed by the Canadian Heart Failure Society,Heart Failure Association of India,Cardiac Society of Australia and New Zealand,and Chinese Heart Failure Association[J]. Eur J Heart Fail,2021,23(3):352-380.

[4] Shang Z,Wang X,Gao W. Heart failure with mildly reduced ejection fraction:emerging frontiers in clinical characteristics,prognosis,and treatment[J]. Rev Cardiovasc Med,2022,23(1):30.

[5] Ni T,Liu Y,Huang M,et al. Association between anemia status and the risk of different types of heart failure:a RCSCD-TCM study in China[J]. Angiology,2024,75(2):190-196.

[6] Koelbl CO,Nedeljkovic ZS,Jacobs AK. Coronary chronic total occlusion(CTO):a review[J]. Rev Cardiovasc M ed,2018,19(1):33-39.

[7] Jaup T,Allemann Y,Urban P,et al. The Magnum wire for percutaneous coronary balloon angioplasty in 723 patients[J]. J Invasive Cardiol,1995,7(9):259-264.

[8] Anker SD,Butler J,Filippatos G,et al. Empagliflozin in Heart failure with a preserved ejection fraction[J]. N Engl J Med,2021,385(16):1451-1461.

[9] di Mario C,Mashayekhi KA,Garbo R,et al. Recanalisation of coronary chronic total occlusions[J]. EuroIntervention,2022,18(7):535-561.

[10] Hoebers LP,Claessen BE,Elias J,et al. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome[J]. Int J Cardiol,2015,187:90-96.

[11] Farag M,Egred M. CTO in contemporary PCI[J]. Curr Cardiol Rev,2022,18(1):e310521193720.

[12] Ren XY,Li YF,Liu HQ,et al. Anti-inflammatory therapy progress in major adverse cardiac events after PCI:Chinese and Western medicine[J]. Chin J Integr Med,2023,29(7):655-664.

[13] Azzalini L,Jolicoeur EM,Pighi M,et al. Epidemiology,management strategies,and outcomes of patients with chronic total coronary occlusion[J]. Am J Cardiol,2016,118(8):1128-1135.

[14] Kosmidou I,Liu Y,Zhang Z,et al. Incidence and prognostic impact of atrial fibrillation after discharge following revascularization for significant left main coronary artery narrowing[J]. Am J Cardiol,2020,125(4):500-506.

[15] Batra G,Svennblad B,Held C,et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome[J]. Heart,2016,102(12):926-933.

[16] Berezin AE,Berezin AA.Adverse cardiac remodelling after acute myocardial infarction:old and new biomarkers[J]. Dis Markers,2020,2020:1215802.

[17] Fan L,Zhang ZL,Tang JN,et al. The age,NT-proBNP,and ejection fraction score as a novel predictor of clinical outcomes in CAD patients after PCI[J]. Clin Appl Thromb Hemost,2022,28:10760296221113345.

[18] Shi Y,He S,Luo J,et al. Lesion characteristics and procedural complications of chronic total occlusion percutaneous coronary intervention in patients with prior bypass surgery:a meta-analysis[J]. Clin Cardiol,2022,45(1):18-30.

[19] Shimada BK,Yang Y,Zhu J,et al. Extracellular miR-146a-5p induces cardiac innate immune response and cardiomyocyte dysfunction[J]. Immunohorizons,2020,4(9):561-572.

[20] Sheng J,Liu N,He F,et al. Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome[J]. Clinics(Sao Paulo),2021,76:e2580.

[21] Yang Y,Huang Y. Association between serum hemoglobin and major cardiovascular adverse event in Chinese patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention[J]. J Clin Lab Anal,2022,36(1):e24126.

相似文献/References:

[1]安明春,杨旭明.冠状动脉慢性完全闭塞病变介入治疗及临床获益研究进展[J].心血管病学进展,2019,(6):860.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.006]
　AN Mingchun,YANG Xuming.Research Progress in Interventional Therapy and Clinical Benefits of CTO Lesions[J].Advances in Cardiovascular Diseases,2019,(11):860.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.006]
[2]董佳佳 于子翔 马依彤.冠状动脉慢性完全闭塞病变血运重建的治疗[J].心血管病学进展,2020,(8):794.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.003]
　DONG Jiajia,YU Zixiang,MA Yitong.Therapeutic Strategy of Revascularization in Patients with Chronic Complete Occlusion[J].Advances in Cardiovascular Diseases,2020,(11):794.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.003]
[3]马兴鸿 汪蕾 方纬.核素心肌显像在冠状动脉慢性完全闭塞临床诊疗中的应用价值[J].心血管病学进展,2022,(4):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
　MA Xinghong,WANG Lei,FANG Wei.Application Value of Radionuclide Myocardial Imaging In the Clinical Diagnosis And Treatment of Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2022,(11):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[4]张颖 集铄媛 谷国强.冠状动脉慢性完全闭塞正向介入治疗技术进展[J].心血管病学进展,2023,(2):122.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.006]
　ZHANG Ying,JI Shuoyuan,GU Guoqiang.Antegrade Approach to Percutaneous Coronary Intervention for Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2023,(11):122.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.006]

更新日期/Last Update: 2024-12-02